BOLD - CIK 0001782303
Boundless Bio, Inc. (BOLD) reported net income of -$58.20M for fiscal year 2025, as filed in its audited annual report with the SEC.
| Fiscal year | Net Income | Change |
|---|---|---|
| FY 2025 | -$58.20M | +11.0% |
| FY 2024 | -$65.36M | -32.2% |
| FY 2023 | -$49.43M | - |
Boundless Bio, Inc. (BOLD) reported net income of -$58.20M for fiscal year 2025, as filed in its audited annual report with the SEC.
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.